Physician profile
Julia G Weeks
NPI 1235208380
$2,615.46
in general payments reported to CMS, 2019-2025
35 companies · $322 in 2025
The $322 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $310 · 2020: $148 · 2021: $441 · 2022: $434 · 2023: $574 · 2024: $387 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,282.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $283.17 | 2019-2023 | |
| Organogenesis INC. | $282.29 | 2023-2025 | Nushield, Affinity, Apligraf |
| Novartis Pharmaceuticals Corporation | $171.50 | 2021-2024 | |
| Smith+Nephew, INC. | $161.16 | 2019-2025 | Collagenase Santyl, Grafix Pl, Oasis |
| Limflow INC. | $157.86 | 2023 | Limflow System |
| Kerecis Limited | $154.24 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Abbvie INC. | $141.62 | 2021-2025 | Dalvance |
| Stryker Corporation | $139.58 | 2025 | Limflow System |
| Novo Nordisk INC | $139.56 | 2020-2023 | Rybelsus, Ozempic |
| Merck Sharp & Dohme LLC | $127.82 | 2021-2022 | |
| Misonix INC | $111.66 | 2021 | |
| Janssen Pharmaceuticals, INC | $103.51 | 2019 | |
| Ets Wound Care LLC | $90.09 | 2023-2025 | Mirragen Advanced Wound Matrix |
| Amgen INC. | $70.32 | 2019-2022 | |
| Abbott Laboratories | $59.20 | 2022-2023 | Freestyle Libre 3 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $48.10 | 2019-2022 | |
| Bioventus LLC | $34.48 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $32.90 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.10 | 2019 | |
| Neurelis, INC. | $27.64 | 2022-2023 | Valtoco |
| Teva Pharmaceuticals USA, INC. | $25.70 | 2022 | |
| Convatec INC. | $20.71 | 2023 | |
| Sanofi-Aventis U.S. LLC | $20.49 | 2019 | |
| Global Blood Therapeutics, INC. | $19.56 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.32 | 2023 | Xifaxan, Trulance |
| Mylan Specialty L.P. | $18.26 | 2020 | |
| Triad Life Sciences INC. | $15.01 | 2022 | |
| Tris Pharma INC | $14.63 | 2019 | |
| Paratek Pharmaceuticals, INC. | $14.31 | 2025 | Nuzyra |
| Lilly USA, LLC | $14.04 | 2020 | |
| Seqirus USA INC | $13.73 | 2020 | |
| Melinta Therapeutics, LLC | $13.63 | 2019 | |
| Exact Sciences Corporation | $12.91 | 2023 | Cologuard Collection Kit |
| Janssen Biotech, INC. | $12.90 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $12.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Weeks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.